The primary objective of this clinical study is to assess the efficacy of a blood test in the early detection of lung cancer. ARC is looking for participants between 50 and 80 years of age who have an increased risk of lung cancer and are undergoing or intend to undergo a low-dose CT scan of the chest for lung cancer screening. Additional criteria may apply.
About the Study